Sputnik V Vaccine Trial Data
- All
- News
- Videos
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
Sputnik Vaccine For India? Regulator Seeks More Data: Report
An expert panel of India's drug regulator on Friday sought additional data from drugmaker Dr.Reddy's Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February.
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
Russia's Covid Vaccine Sputnik Shows 91.4% Efficacy In New Trial: Report
Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine on Monday based on new data, and said the shot had again been found to be 91.4 per cent effective in providing protection from COVID-19.
-
Russia Says Its Sputnik V COVID-19 Vaccine 95% Effective
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
Sputnik Vaccine For India? Regulator Seeks More Data: Report
An expert panel of India's drug regulator on Friday sought additional data from drugmaker Dr.Reddy's Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February.
-
Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial
The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials
-
Russia's Covid Vaccine Sputnik Shows 91.4% Efficacy In New Trial: Report
Russian coronavirus vaccine developers published fresh results from their trial of the Sputnik V vaccine on Monday based on new data, and said the shot had again been found to be 91.4 per cent effective in providing protection from COVID-19.
-
Russia Says Its Sputnik V COVID-19 Vaccine 95% Effective
Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on Tuesday.
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
